FDA Updates Labeling on Febrile Seizure Risks i...

By João L. Carapinha

January 19, 2026

FDA Labeling Mandate on Febrile Seizure Risks In a significant update to vaccine safety protocols, the U.S. Food and Drug Administration (FDA) has required pediatric influenza vaccines t...
Guiding Principles for Ethical AI Integration in Drug Development
Obesity Medication Guidelines: Evidence-Based Approaches to Effective Treatment
β-Blockers Myocardial Infarction: Reevaluating Their Role in Patients with Pr...
Johnson & Johnson’s Medicine Access Agreement: Paving the Way for ...
Childhood Immunization Reforms: Aligning U.S. Schedules with Global Standards
Novartis Drug Pricing Agreement
Strategic Avalere Health Appointments Enhance Leadership in Navigating US Hea...
Positive ARTISTRY-2 Trial Results for BIC LEN HIV Regimen
Accelerating Tec-Dara Multiple Myeloma Therapy Review: A Game Changer for Pat...
AKEEGA BRCA2 Approval: Landmark FDA Decision for Precision Therapy in Aggress...
Innovations in Haematology Cell Therapy at ASH 2025
Biomanufacturing Excellence Act: Strengthening U.S. Biopharmaceutical Manufac...